Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine Sedation for Pediatric MRI
NCT05091151Completed
- Sponsor
- Universitas Indonesia
- Start
- Feb 2019
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Onset sedation time of Intranasal dexmedetomidine. Started Feb 2019; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT05091151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05091151.